GlassScriptPhysician profile
Robin M Gehrmann
NPI 1871675512
$5,449.29
in general payments reported to CMS, 2019-2025
15 companies · $3,650 in 2025
The $3,650 reported for 2025 was more than what 77% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $106 · 2021: $1,239 · 2022: $46.53 · 2023: $25.12 · 2025: $3,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,000 · Travel and Lodging: $480 · Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $480.01 |
| Food and Beverage | $195.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acuitive Technologies, INC | $3,102.44 | 2025 | 9 X 33mm Citrelock Acl Implant, 7 X 23mm Citrelock Acl Implant, 8 X 28mm Citrelock Acl Implant |
| Seapearl East, INC | $1,200.00 | 2021 | |
| Medical Device Business Services, INC. | $527.33 | 2025 | Na |
| Stryker Corporation | $273.42 | 2019-2020 | |
| Vericel Corporation | $54.46 | 2019-2022 | |
| Bioventus LLC | $53.94 | 2019-2022 | |
| Smith+Nephew, INC. | $44.10 | 2019 | |
| Royal Biologics, INC. | $39.49 | 2021 | |
| Fidia Pharma USA INC. | $33.14 | 2020 | |
| Depuy Synthes Sales INC. | $32.51 | 2019 | |
| Zimmer Biomet Holdings, INC. | $25.12 | 2023 | Quattro |
| Ossur Americas, INC. | $20.58 | 2025 | Unloader One X |
| Fujifilm New Development USA, INC. | $14.60 | 2019 | |
| Pacira Therapeutics, INC. | $14.40 | 2020 | |
| Ermi LLC | $13.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$150,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Gehrmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.